Intranasal influenzavirus vaccine in children. Edwards KM, Dupont WD (1998) N Engl J Med 339: 922; author reply 922-3 The underrecognized burden of influenza in young children. Poehling KA, Edwards KM, Weinberg GA, Szilagyi P, Staat MA, Iwane MK, Bridges CB, Grijalva CG, Zhu Y, Bernstein DI, Herrera G, Erdman D, Hall CB, Seither R, Griffin MR, New Vaccine Surveillance Network (2006) N Engl J Med 355: 31-40 Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses. Joyce MG, Wheatley AK, Thomas PV, Chuang GY, Soto C, Bailer RT, Druz A, Georgiev IS, Gillespie RA, Kanekiyo M, Kong WP, Leung K, Narpala SN, Prabhakaran MS, Yang ES, Zhang B, Zhang Y, Asokan M, Boyington JC, Bylund T, Darko S, Lees CR, Ransier A, Shen CH, Wang L, Whittle JR, Wu X, Yassine HM, Santos C, Matsuoka Y, Tsybovsky Y, Baxa U, NISC Comparative Sequencing Program, Mullikin JC, Subbarao K, Douek DC, Graham BS, Koup RA, Ledgerwood JE, Roederer M, Shapiro L, Kwong PD, Mascola JR, McDermott AB (2016) Cell 166: 609-623 Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Xu R, Ekiert DC, Krause JC, Hai R, Crowe JE, Wilson IA (2010) Science 328: 357-60 Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination. Grijalva CG, Zhu Y, Williams DJ, Self WH, Ampofo K, Pavia AT, Stockmann CR, McCullers J, Arnold SR, Wunderink RG, Anderson EJ, Lindstrom S, Fry AM, Foppa IM, Finelli L, Bramley AM, Jain S, Griffin MR, Edwards KM (2015) JAMA 314: 1488-97 H7N9 influenza virus neutralizing antibodies that possess few somatic mutations. Thornburg NJ, Zhang H, Bangaru S, Sapparapu G, Kose N, Lampley RM, Bombardi RG, Yu Y, Graham S, Branchizio A, Yoder SM, Rock MT, Creech CB, Edwards KM, Lee D, Li S, Wilson IA, García-Sastre A, Albrecht RA, Crowe JE (2016) J Clin Invest 126: 1482-94 Universal flu vaccines: primum non nocere. Crowe JE (2013) Sci Transl Med 5: 200fs34 Vaccine-elicited antibody that neutralizes H5N1 influenza and variants binds the receptor site and polymorphic sites. Winarski KL, Thornburg NJ, Yu Y, Sapparapu G, Crowe JE, Spiller BW (2015) Proc Natl Acad Sci U S A 112: 9346-51 Influenza vaccination of healthcare workers: making the grade for action. Griffin MR (2014) Clin Infect Dis 58: 58-60 Effectiveness of influenza vaccine for preventing laboratory-confirmed influenza hospitalizations in adults, 2011-2012 influenza season. Talbot HK, Zhu Y, Chen Q, Williams JV, Thompson MG, Griffin MR (2013) Clin Infect Dis 56: 1774-7 Cohort profile: The study of respiratory pathogens in Andean children. Grijalva CG, Griffin MR, Edwards KM, Williams JV, Gil AI, Verastegui H, Hartinger SM, Vidal JE, Klugman KP, Lanata CF (2014) Int J Epidemiol 43: 1021-30 A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. Edwards KM, Dupont WD, Westrich MK, Plummer WD, Palmer PS, Wright PF (1994) J Infect Dis 169: 68-76 Impact of body mass index on immunogenicity of pandemic H1N1 vaccine in children and adults. Callahan ST, Wolff M, Hill HR, Edwards KM, NIAID Vaccine and Treatment Evaluation Unit (VTEU) Pandemic H1N1 Vaccine Study Group (2014) J Infect Dis 210: 1270-4 Effectiveness of seasonal vaccine in preventing confirmed influenza-associated hospitalizations in community dwelling older adults. Talbot HK, Griffin MR, Chen Q, Zhu Y, Williams JV, Edwards KM (2011) J Infect Dis 203: 500-8 Cutting edge: molecular portrait of human autoimmune disease. Maas K, Chan S, Parker J, Slater A, Moore J, Olsen N, Aune TM (2002) J Immunol 169: 5-9 Hemagglutinin linear epitope presentation on monolayer-protected clusters elicits strong antibody binding. Gerdon AE, Wright DW, Cliffel DE (2005) Biomacromolecules 6: 3419-24 Decreased antibody response to influenza vaccination in kidney transplant recipients: a prospective cohort study. Birdwell KA, Ikizler MR, Sannella EC, Wang L, Byrne DW, Ikizler TA, Wright PF (2009) Am J Kidney Dis 54: 112-21 Influenza-related hospitalization and ED visits in children less than 5 years: 2000-2011. Jules A, Grijalva CG, Zhu Y, Talbot HK, Williams JV, Poehling KA, Chaves SS, Edwards KM, Schaffner W, Shay DK, Griffin MR (2015) Pediatrics 135: e66-74 The burden of influenza in young children, 2004-2009. Poehling KA, Edwards KM, Griffin MR, Szilagyi PG, Staat MA, Iwane MK, Snively BM, Suerken CK, Hall CB, Weinberg GA, Chaves SS, Zhu Y, McNeal MM, Bridges CB (2013) Pediatrics 131: 207-16 Predictors of influenza virus vaccination status in hospitalized children. Poehling KA, Speroff T, Dittus RS, Griffin MR, Hickson GB, Edwards KM (2001) Pediatrics 108: E99 Disparities between black and white children in hospitalizations associated with acute respiratory illness and laboratory-confirmed influenza and respiratory syncytial virus in 3 US counties--2002-2009. Iwane MK, Chaves SS, Szilagyi PG, Edwards KM, Hall CB, Staat MA, Brown CJ, Griffin MR, Weinberg GA, Poehling KA, Prill MM, Williams JV, Bridges CB (2013) Am J Epidemiol 177: 656-65 Proteomics show antigen presentation processes in human immune cells after AS03-H5N1 vaccination. Galassie AC, Goll JB, Samir P, Jensen TL, Hoek KL, Howard LM, Allos TM, Niu X, Gordy LE, Creech CB, Hill H, Joyce S, Edwards KM, Link AJ (2017) Proteomics 17: Duration of virus shedding after trivalent intranasal live attenuated influenza vaccination in adults. Talbot TR, Crocker DD, Peters J, Doersam JK, Ikizler MR, Sannella E, Wright PE, Edwards KM (2005) Infect Control Hosp Epidemiol 26: 494-500 Update on vaccination guidelines for older adults. Pilkinton MA, Talbot HK (2015) J Am Geriatr Soc 63: 584-8 Impact of maternal immunization on influenza hospitalizations in infants. Poehling KA, Szilagyi PG, Staat MA, Snively BM, Payne DC, Bridges CB, Chu SY, Light LS, Prill MM, Finelli L, Griffin MR, Edwards KM, New Vaccine Surveillance Network (2011) Am J Obstet Gynecol 204: S141-8 The population impact of a large school-based influenza vaccination campaign. Grijalva CG, Zhu Y, Simonsen L, Mitchel E, Griffin MR (2010) PLoS One 5: e15097 Cell-Based Systems Biology Analysis of Human AS03-Adjuvanted H5N1 Avian Influenza Vaccine Responses: A Phase I Randomized Controlled Trial. Howard LM, Hoek KL, Goll JB, Samir P, Galassie A, Allos TM, Niu X, Gordy LE, Creech CB, Prasad N, Jensen TL, Hill H, Levy SE, Joyce S, Link AJ, Edwards KM (2017) PLoS One 12: e0167488 Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities. Griffin MR, Monto AS, Belongia EA, Treanor JJ, Chen Q, Chen J, Talbot HK, Ohmit SE, Coleman LA, Lofthus G, Petrie JG, Meece JK, Hall CB, Williams JV, Gargiullo P, Berman L, Shay DK, U.S. Flu-VE Network (2011) PLoS One 6: e23085 A cell-based systems biology assessment of human blood to monitor immune responses after influenza vaccination. Hoek KL, Samir P, Howard LM, Niu X, Prasad N, Galassie A, Liu Q, Allos TM, Floyd KA, Guo Y, Shyr Y, Levy SE, Joyce S, Edwards KM, Link AJ (2015) PLoS One 10: e0118528 Clinical assessment of serious adverse events in children receiving 2009 H1N1 vaccination. Pahud BA, Williams SE, Dekker CL, Halsey N, Larussa P, Baxter RP, Klein NP, Marchant CD, Sparks RC, Jakob K, Aukes L, Swope S, Barnett E, Lewis P, Berger M, Dreskin SC, Donofrio PD, Sejvar JJ, Slade BA, Gidudu J, Vellozzi C, Edwards KM (2013) Pediatr Infect Dis J 32: 163-8 Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Neuzil KM, Dupont WD, Wright PF, Edwards KM (2001) Pediatr Infect Dis J 20: 733-40 Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009. Chen WH, Winokur PL, Edwards KM, Jackson LA, Wald A, Walter EB, Noah DL, Wolff M, Kotloff KL, Pandemic H1N1 Vaccine Adult Study Group (2012) Vaccine 30: 4240-8 Association between obesity and vulnerability and serologic response to influenza vaccination in older adults. Talbot HK, Coleman LA, Crimin K, Zhu Y, Rock MT, Meece J, Shay DK, Belongia EA, Griffin MR (2012) Vaccine 30: 3937-3943 Establishing the baseline burden of influenza in preparation for the evaluation of a countywide school-based influenza vaccination campaign. Grijalva CG, Zhu Y, Simonsen L, Griffin MR (2010) Vaccine 29: 123-9 Immune responses of infants to infection with respiratory viruses and live attenuated respiratory virus candidate vaccines. Crowe JE (1998) Vaccine 16: 1423-32 Vitamin D is not associated with serologic response to influenza vaccine in adults over 50 years old. Sundaram ME, Talbot HK, Zhu Y, Griffin MR, Spencer S, Shay DK, Coleman LA (2013) Vaccine 31: 2057-61 Evidence of effectiveness from a large county-wide school-based influenza immunization campaign. Grijalva CG, Zhu Y, Griffin MR (2009) Vaccine 27: 2633-6 Atopy history and the genomics of wheezing after influenza vaccination in children 6-59 months of age. Miller EK, Dumitrescu L, Cupp C, Dorris S, Taylor S, Sparks R, Fawkes D, Frontiero V, Rezendes AM, Marchant C, Edwards KM, Crawford DC (2011) Vaccine 29: 3431-7 Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: reports to VAERS. Halsey NA, Griffioen M, Dreskin SC, Dekker CL, Wood R, Sharma D, Jones JF, LaRussa PS, Garner J, Berger M, Proveaux T, Vellozzi C, Hypersensitivity Working Group of the Clinical Immunization Safety Assessment Network, Broder K, Setse R, Pahud B, Hrncir D, Choi H, Sparks R, Williams SE, Engler RJ, Gidudu J, Baxter R, Klein N, Edwards K, Cano M, Kelso JM (2013) Vaccine 31: 6107-12 An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines. Murphy BR, Hall SL, Kulkarni AB, Crowe JE, Collins PL, Connors M, Karron RA, Chanock RM (1994) Virus Res 32: 13-36
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.